Last reviewed · How we verify
NCT05756725
Improving Cancer Screening and Follow-up in Community Health Centers
NA trial testing Practice-Level Implementation Strategies in Breast Cancer Screening in 8 participants. Completed in 4 January 2024.
4 January 2024
Quick facts
| Lead sponsor | Harvard School of Public Health (HSPH) |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 8 |
| Start date | 25 July 2023 |
| Primary completion | 4 January 2024 |
| Estimated completion | 4 January 2024 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Practice-Level Implementation Strategies
Conditions studied
- Breast Cancer Screening — all drugs for Breast Cancer Screening →
- Colorectal Cancer Screening — all drugs for Colorectal Cancer Screening →
- Implementation — all drugs for Implementation →
Sponsor
Harvard School of Public Health (HSPH)
Who can join
18 and older, any sex, with Breast Cancer Screening or Colorectal Cancer Screening. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an implementation science study that examines implementation of a single intervention and the development of practice-level implementation strategies to facilitate implementation of the intervention.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Current Progress in Clinical Research in Secondary Prevention and Early Detection of Colorectal Cancer.
Partyka O, Pajewska M, Czerw A, Deptała A, et al · · 2025 · cited 2× · PMID 39941735 · DOI 10.3390/cancers17030367
Verify or expand the search:
- PubMed search for NCT05756725
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer Screening
Currently open trials in the same condition.
- NCT07067788 — B.Brilliant Revelation Comparision Study · recruiting
- NCT06934239 — A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detec · Phase 4 · recruiting
- NCT07075679 — Screening Mammography: Single Reading by One Radiologist With AI vs. Double Reading by Two Radiologists (AI-BCSQ) · NA · recruiting
- NCT06876610 — Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer · recruiting
- NCT07411443 — AI-Enhanced Imaging in Population Breast Cancer Screening · NA · recruiting
Other Harvard School of Public Health (HSPH) trials
Trials by the same sponsor.
- NCT07493772 — Multiple Micronutrient Supplementation With Digital Layering Among Adolescents in Tanzania · NA · not yet recruiting
- NCT06982339 — Beat the Heat Boston · NA · recruiting
- NCT06765863 — LIFT-UP: Randomized Controlled Trial of Fortification of Human Milk · NA · recruiting
- NCT06102044 — Zinc Supplementation for Young Infants With Clinical Severe Infection in Tanzania · Phase 3 · recruiting
- NCT06390943 — Low Birthweight and Preterm Infant Feeding Trial and Supportive Care Package: Implementation Research · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05756725 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Harvard School of Public Health (HSPH)
- Last refreshed: 26 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05756725.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing